Reasons for hospital-level variations in bleeding post-angioplasty are unclear

April 18, 2016

WASHINGTON (April 18, 2016) --The use of bleeding avoidance strategies has only a modest effect on the variation in bleeding rates post-angioplasty among hospitals performing this procedure, leaving about 70 percent of the causes for this variation unexplained, according to a study published today in JACC: Cardiovascular Interventions.

The study also examined whether patients treated with bleeding avoidance strategies were those at low risk for this complication, not high-risk patients who potentially would benefit more. This a risk-treatment paradox--when patients who need an intervention the most receive it the least frequently--has been demonstrated in previous studies.

Using data from the American College of Cardiology NCDR CathPCI Registry, researchers examined records from almost 2.5 million procedures at 1,358 sites between 2009 and 2013. In conducting their analysis, researchers adjusted for patient risk, considering such variables as gender, age, body mass index, the presence of cerebrovascular disease, prior angioplasty and diabetes. They also looked at whether combinations of bleeding avoidance strategies--use of the radial artery for access during angioplasty, administering the blood thinner bivalirudin, and sealing off the point of access with a vascular closure device--had an impact on bleeding totals.

Throughout the study period, researchers observed 125,361 bleeding events. Patients who had the procedure done with radial access had less bleeding than those who did not: 5 percent vs. 11.2 percent. Bivalirudin therapy was used less frequently among patients who experienced bleeding: 43.8 percent vs. 59.4 percent--and vascular closure devices were used at lower rates: 32.9 percent vs. 42.4 percent.

Consistent with previous research, the study also demonstrated the risk-treatment paradox. Patients receiving bleeding avoidance strategies had a predicted bleeding risk of 3.2 percent, compared with a predicted bleeding risk of 4.5 percent among those not receiving these strategies.

Overall, researchers found that the median hospital rate of use of any bleeding avoidance strategy was 86.6 percent. Increased use of these strategies was associated with decreased probability of an individual bleeding event.

The study also showed a significant variation in bleeding rates among hospitals, just as previous studies had found. After incorporating individual patient risk for bleeding, hospital rates for bleeding varied from 2.6 percent to 9.3 percent. With bleeding avoidance strategies having only a small effect on overall hospital-level variation, about 70 percent of the variation among hospitals remains unexplained.

Amit N. Vora, M.D., M.P.H., the study's lead author and a cardiologist with the Duke Research Institute in Durham, North Carolina, said that "these findings have several implications for both clinical care and quality improvement." He said that when hospitals used bleeding avoidance strategies in more than 85 percent of patients, bleeding rates were lower, "demonstrating that an approach to broaden the use of these strategies in all patients--overcoming the 'risk-treatment paradox'--may be a reasonable way to reduce overall variation in hospital bleeding rates."

Vora also addressed limitations associated with using post-procedure bleeding as a performance measure for hospitals. Because almost 70 percent of bleeding rates remain unexplained, "the stringent use of bleeding rate measures to determine reimbursement rates or to penalize institutions by payers and regulators may be premature at this time," he said.

According to Vora, the next best step is to perform "further analyses to determine the causes of variation in bleeding following angioplasty among hospitals, including the use of vascular ultrasound during the procedure when using the femoral artery as the access point, along with using protocols to stop bleeding."
JACC: Cardiovascular Interventions is the leading subspecialty cardiology journal in impact factor and circulation.

The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit

American College of Cardiology

Related Angioplasty Articles from Brightsurf:

Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty
A new study found the rate of heart attack and severe complications before, during or soon after elective surgery to open a blocked artery was similar between patients treated with clopidogrel and those who received the more potent antiplatelet medication ticagrelor.

Study finds significant variability in doctors' angioplasty death rates
Some doctors have higher or lower than expected death rates from coronary angioplasty procedures, also known as percutaneous coronary intervention (PCI); however, doctors should not be judged solely on the rate of patients who die from the procedure.

Beta-blockers following angioplasty show little benefit for some older patients
Following coronary angioplasty, beta-blockers did not significantly improve mortality rates or reduce the number of future cardiovascular incidents for older patients with stable angina but no history of heart attack or heart failure, according to a study published today in the JACC: Cardiovascular Interventions.

Sleep disorders may predict heart events after angioplasty
People who have had procedures to open blocked heart arteries after acute coronary syndrome (ACS) may have a higher risk of death, heart failure, heart attack and stroke if they have sleep disorders, such as sleep apnea, compared to those who don't.

Reasons for hospital-level variations in bleeding post-angioplasty are unclear
The use of bleeding avoidance strategies has only a modest effect on the variation in bleeding rates post-angioplasty among hospitals performing this procedure, leaving about 70 percent of the causes for this variation unexplained, according to a study published today in JACC: Cardiovascular Interventions.

US prediction models for kidney injury following angioplasty hold up in Japan
Models developed by the American College of Cardiology NCDR CathPCI Registry to predict the likelihood of angioplasty patients developing acute kidney injury and acute kidney injury requiring dialysis have proven to be effective among patients in Japan.

IV beta blockers before angioplasty are safe, but offer no clinical benefit
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack -- ST-segment elevation myocardial infarction (STEMI) -- was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

Life-threatening bowel ischemia can often be treated by balloon angioplasty
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland.

Radial access used less than femoral approach for emergency angioplasty
Although using the radial artery as the access point for angioplasty has been linked to reduced bleeding compared to use of the femoral artery, only a small number of high-risk heart attack patients who undergo rescue angioplasty -- emergency procedures following failed therapy with clot-busting drugs -- are treated by radial access, according to a study published today in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Use of rarely appropriate angioplasty procedures declined sharply
The number of angioplasty procedures classified as rarely appropriate declined sharply between 2010 and 2014, as did the number of those performed on patients with non-acute conditions, according to a study published today in the Journal of the American Medical Association and simultaneously presented at a meeting of the American Heart Association in Orlando.

Read More: Angioplasty News and Angioplasty Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to